On a magic taxi ride. Well, you don't know what we can see. Why don't you tell your dreams to me. Fantasy will set you free...
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I can't believe it PAOG at this level is a total gift. Penny land is knocking.
It should move some institutional money in as well. Very nice for investors indeed. $GTBP
You don't bring a team like that together in a go nowhere shell. They see a real chance to make medical history with $GTBP.
Chronic pain treatment is a massive market.
It's like the Avengers of biopharma! Haha, banded together to defeat cancer once for all. But seriously it's an extraordinarily talented team. Winning is the only option.
Wow! Fantastic write up for $GTBP. Great find. Thanks for posting.
And super encouraging for the cancer treatment sector.
Great post!
Your thinking seems sound to me. Add to that the specialities of the execs they've been recruiting and the whole puzzle picture comes into view. Lots of massive fundraising specialists as well as leaders with the particular kind of finance expertise needed to manage the more stringent reporting and requirements of a NASDAQ uplist.
NASDAQ uplisting would be stellar.
Agreed. You've got one Ivy League MBA / PHD after another with mega biopharma prior success lining up for a slice of the pie. Smart people smelling money is what I say. Mama always taught me never buy a dinner at an empty restaurant.
Phase 2 completion would be massive milestone.
In the January letter to investors they speak of it like 2018 will see a NASDAQ uplisting for sure.
Early testing very hopeful with cases of tumors shrinking and going into remission. Very good news in this world.
The aggressive expansion is keeping me very Bullish here.
$PAOG at this level is a huge discount. This will go back to a penny easy once it corrects.
Haha Agreed! LONGS know we are holding onto a gem here.
Looks like 1.49 EoD
A buyback program! Any links?
Let's see if there's any last minute trades coming through to tip us to green....
A strong PR about the progress of NASDAQ uplisting seems overdue. That could be a catalyst for a major buying frenzy.
Another big churning day here. Interest keeps building.
AWESOME! I love the investor buzz growing around GTBP!
Agreed LONG is the way to play this.
Good thing is if they don't make it at first pass, this is not the kind of executive team to give up on that.
A NASDAQ Uplisting also holds out the hope of big institutional money coming in. They have the right exec team now to court that kind of thing.
Great post! You took the words right out of my mouth.
Do I need to point out that spread. CMON mms!
Oh cmon now! Lay off that bid already!
The good thing is whether the application has been stalled out or just not yet processed, GTBP has been stacking the bench in the past months with team members who can realistically help guide the journey to NASDAQ.
Yes. Another possibility is that the application process has been stalled penning some not yet met criteria. Could be why GTBP keeps on recruiting people to the team that can help get to the next level.
Lateral move at the moment. Good day to shake out swing traders and plank in more LONG investors.
REGARDING NASDAQ Uplisting. From the January 24 "Letter to Shareholders"
Increasing our Profile on Wall Street and Preparing for a NASDAQ Uplisting
Throughout 2017, and accelerating towards the end of last year, we worked on putting the pieces in place to prepare for an uplisting on NASDAQ and to increase our profile with the institutional investor community. On December 18, 2017, we took the first step in the uplisting process and announced our intention to apply for listing on the Nasdaq Capital Markets exchange. In January 2018, we filed our application for that listing.
We have also spent the past couple of months meeting with key players on Wall Street to help increase our profile with the institutional investor community. We were recently invited to present at the 30th Annual ROTH Conference; which takes place on March 11-13, 2018, at The Ritz-Carlton in Orange County, CA. We will provide a separate communication that provides more details about our attendance at that investor conference. Our management team will be attending several other scientific and investor events throughout the year and we look forward to providing updates as appropriate.
Going Forward
We expect 2018 to be a similarly productive year as compared to 2017 but with more of an emphasis on creating shareholder value by hitting our clinical and pre-clinical milestones vs reducing debt and recruiting management. We anticipate we will be listed on NASDAQ and will appoint additional experienced employees and board members. We will work hard to increase our presence amongst the leading institutional investors on Wall Street and attract and maintain a high-quality shareholder base. We will continue to have our shareholders as our top priority and will be singularly focused on working to create significant shareholder value over time.
https://www.gtbiopharma.com/news-media/press-releases/detail/134/gt-biopharma-inc-issues-letter-to-shareholders
It gives some reassurance to shareholders definitely.
Case in point. If his last venture ended in a buyout of $1.2Billion, I doubt he'd get involved here unless he saw a similar potential for GTBP, at least IMHO. Something to ponder for sure.
Yeah everything points to a massive play developing. When they have people joining the team who have been in the same room where buyout deals of a Billion plus were finalized, you can speculate that something very very big might be on the horizon.
Massive asset to the company. Graduate of Yale and Harvard both cum laude. Well when you are trying to cure cancer you need the biggest brains on the team that money can buy.
That's quite helpful thanks for posting.
NASDAQ uplisting would be a major milestone and growth catalyst for the ticker.
That is very good news. I've had several relatives go through chemotherapy and it SSSSUUUUUCCKKKED big time. You watch someone going through that and you have to ask yourself is the cure almost as bad as the disease. As I understand it the treatments being worked on by GBPT revolve around triggering the body's own immune system to aggressively combat the cancer.